CERLIPONASE ALFA

CERLIPONASE ALFA was reported 536 times

CERLIPONASE ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CSF CULTURE POSITIVE 26 0.2453
1 CSF EOSINOPHIL COUNT INCREASED 1 0.2000
2 CATHETER SITE FIBROSIS 1 0.1111
3 INTERNAL DEVICE EXPOSED 1 0.1111
4 SUBCUTANEOUS FLUID COLLECTION 1 0.1000
5 STATUS DYSTONICUS 1 0.0667
6 CSF RED BLOOD CELL COUNT POSITIVE 2 0.0571
7 MEDICAL DEVICE SITE OEDEMA 1 0.0476
8 CNS VENTRICULITIS 12 0.0368
9 CSF WHITE BLOOD CELL COUNT INCREASED 6 0.0314
10 AUTOMATISM EPILEPTIC 1 0.0278
11 DEVICE END OF SERVICE 1 0.0270
12 AQUEDUCTAL STENOSIS 1 0.0263
13 WANDERING PACEMAKER 1 0.0222
14 GASTROINTESTINAL TUBE REMOVAL 1 0.0222
15 MEDICAL DEVICE SITE HAEMATOMA 1 0.0217
16 PLEOCYTOSIS 12 0.0206
17 AUTONOMIC FAILURE SYNDROME 1 0.0172
18 CUTIBACTERIUM ACNES INFECTION 1 0.0169
19 CATHETER SITE SCAR 1 0.0167
20 PUNCTURE SITE INFECTION 1 0.0161
21 PUNCTURE SITE HAEMATOMA 1 0.0156
22 FACTOR VII DEFICIENCY 1 0.0149
23 CSF WHITE BLOOD CELL COUNT POSITIVE 1 0.0135
24 CEREBRAL VENTRICLE COLLAPSE 1 0.0133
25 MEDICAL DEVICE SITE SWELLING 2 0.0116
26 ADMINISTRATION SITE INFLAMMATION 1 0.0111
27 SUBDURAL EFFUSION 1 0.0109
28 EYELID MYOCLONUS 1 0.0100
29 GASTROSTOMY TUBE SITE COMPLICATION 2 0.0100
30 PROPIONIBACTERIUM INFECTION 1 0.0093
31 CSF GLUCOSE DECREASED 1 0.0086
32 INADVERTENT INJECTION AIR BUBBLE 1 0.0079
33 MENINGITIS STAPHYLOCOCCAL 1 0.0070
34 CSF CELL COUNT INCREASED 1 0.0068
35 CATHETER SITE SWELLING 6 0.0064
36 PSEUDOMENINGOCELE 1 0.0064
37 CENTRAL NERVOUS SYSTEM INFECTION 7 0.0061
38 CSF TEST ABNORMAL 3 0.0060
39 MEDICAL DEVICE CHANGE 3 0.0056
40 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1 0.0043
41 RETINAL DYSTROPHY 1 0.0042
42 CYANOSIS CENTRAL 1 0.0038
43 DEJA VU 1 0.0036
44 MEDICAL DEVICE SITE HAEMORRHAGE 1 0.0035
45 ASPIRATION BRONCHIAL 1 0.0034
46 MENINGOCOCCAL INFECTION 1 0.0032
47 PNEUMOCEPHALUS 1 0.0030
48 GAZE PALSY 5 0.0029
49 TENOPLASTY 1 0.0029
50 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
51 FEEDING TUBE USER 1 0.0027
52 CEREBRAL VENTRICLE DILATATION 3 0.0026
53 DEPENDENCE ON RESPIRATOR 1 0.0025
54 INCISION SITE IMPAIRED HEALING 1 0.0025
55 FEBRILE CONVULSION 3 0.0025
56 LACK OF SPONTANEOUS SPEECH 1 0.0023
57 CEREBELLAR ATROPHY 2 0.0023
58 OFF LABEL USE OF DEVICE 3 0.0022
59 RIGHT VENTRICULAR HYPERTROPHY 2 0.0022
60 CEREBROSPINAL FLUID LEAKAGE 4 0.0022
61 INFUSION SITE HAEMATOMA 1 0.0021
62 MENINGITIS BACTERIAL 3 0.0021
63 BODY HEIGHT INCREASED 1 0.0020
64 DEVICE RELATED INFECTION 31 0.0020
65 MYOCLONIC EPILEPSY 3 0.0020
66 TRACHEAL DISORDER 1 0.0019
67 CATHETER SITE ERYTHEMA 4 0.0019
68 LANGUAGE DISORDER 4 0.0018
69 CATHETER SITE INFLAMMATION 1 0.0018
70 RETINAL VASCULAR DISORDER 1 0.0017
71 PNEUMOCOCCAL INFECTION 1 0.0017
72 STOMA SITE HYPERGRANULATION 1 0.0016
73 WHITE MATTER LESION 2 0.0016
74 CHANGE IN SEIZURE PRESENTATION 1 0.0015
75 RETINAL DEGENERATION 2 0.0015
76 CEREBRAL ATROPHY 6 0.0015
77 CHOREOATHETOSIS 1 0.0015
78 DERMATITIS DIAPER 1 0.0014
79 PUNCTURE SITE HAEMORRHAGE 1 0.0014
80 RESPIRATORY SYMPTOM 4 0.0014
81 INFANTILE SPASMS 1 0.0014
82 CLONIC CONVULSION 1 0.0014
83 RETINAL VASCULAR OCCLUSION 1 0.0014
84 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
85 LABORATORY TEST INTERFERENCE 1 0.0013
86 CSF PROTEIN INCREASED 1 0.0012
87 SEIZURE CLUSTER 1 0.0012
88 MENINGITIS 8 0.0012
89 CULTURE POSITIVE 1 0.0012
90 PETIT MAL EPILEPSY 6 0.0012
91 MYOCLONUS 14 0.0012
92 TONGUE MOVEMENT DISTURBANCE 1 0.0012
93 DEVICE OCCLUSION 16 0.0011
94 UPPER AIRWAY OBSTRUCTION 1 0.0011
95 NUCHAL RIGIDITY 1 0.0011
96 CATARRH 1 0.0011
97 CLONUS 3 0.0011
98 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
99 POSTICTAL STATE 1 0.0010
100 HYPOPERFUSION 1 0.0010
101 HYDROCEPHALUS 5 0.0009
102 BACTERIAL TEST POSITIVE 2 0.0009
103 DENGUE FEVER 2 0.0009
104 RETINAL VASCULITIS 1 0.0008
105 DEVICE INFUSION ISSUE 2 0.0008
106 CATHETER SITE HAEMORRHAGE 2 0.0008
107 BRONCHIAL SECRETION RETENTION 1 0.0008
108 DYSTONIA 15 0.0008
109 SLOW RESPONSE TO STIMULI 1 0.0008
110 TONIC CLONIC MOVEMENTS 1 0.0008
111 PARTIAL SEIZURES 4 0.0008
112 LARYNGOSPASM 2 0.0007
113 EFFUSION 1 0.0007
114 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
115 TONIC CONVULSION 1 0.0007
116 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
117 SEIZURE 79 0.0007
118 EXCESSIVE EYE BLINKING 1 0.0007
119 INFECTIOUS PLEURAL EFFUSION 1 0.0007
120 MASTICATION DISORDER 2 0.0007
121 DEVICE LEAKAGE 28 0.0006
122 GASTROSTOMY 1 0.0006
123 CYANOSIS 10 0.0006
124 STATUS EPILEPTICUS 7 0.0006
125 OROPHARYNGEAL BLISTERING 1 0.0006
126 PITUITARY TUMOUR BENIGN 1 0.0006
127 SUSPECTED COVID-19 2 0.0006
128 PUPIL FIXED 1 0.0006
129 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
130 AURA 1 0.0005
131 INFECTED SKIN ULCER 1 0.0005
132 RHINOVIRUS INFECTION 2 0.0005
133 FOAMING AT MOUTH 1 0.0005
134 TONGUE BITING 1 0.0005
135 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
136 LIVEDO RETICULARIS 1 0.0005
137 WALKING DISABILITY 1 0.0005
138 DEVICE CONNECTION ISSUE 1 0.0005
139 NEUROGENIC BLADDER 1 0.0005
140 EYE CONTUSION 1 0.0005
141 MENINGITIS ASEPTIC 2 0.0004
142 BODY TEMPERATURE INCREASED 9 0.0004
143 EYE MOVEMENT DISORDER 3 0.0004
144 EYELID DISORDER 1 0.0004
145 VARICELLA 1 0.0004
146 STARING 1 0.0004
147 SLOW SPEECH 1 0.0004
148 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
149 HYPOTONIA 4 0.0004
150 MOTOR DYSFUNCTION 4 0.0004
151 CATHETER SITE PAIN 1 0.0004
152 TONSILLITIS 2 0.0004
153 WEIGHT BEARING DIFFICULTY 1 0.0004
154 BEHAVIOUR DISORDER 2 0.0004
155 INTRACRANIAL PRESSURE INCREASED 2 0.0004
156 LUNG CONSOLIDATION 1 0.0004
157 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
158 HYPERCAPNIA 1 0.0003
159 BRAIN DEATH 1 0.0003
160 POSTURE ABNORMAL 1 0.0003
161 HYPOVENTILATION 1 0.0003
162 REGURGITATION 1 0.0003
163 GRANULOMA 1 0.0003
164 DEVICE PLACEMENT ISSUE 1 0.0003
165 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
166 NEEDLE ISSUE 8 0.0003
167 DEVICE KINK 1 0.0003
168 RETINOPATHY 1 0.0003
169 IMPULSIVE BEHAVIOUR 1 0.0003
170 CATHETER SITE INFECTION 1 0.0003
171 PYREXIA 91 0.0003
172 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
173 COMMUNICATION DISORDER 1 0.0003
174 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
175 REHABILITATION THERAPY 1 0.0003
176 APNOEA 2 0.0003
177 CARDIOPULMONARY FAILURE 1 0.0003
178 WOUND SECRETION 1 0.0003
179 ATAXIA 3 0.0003
180 SOCIAL PROBLEM 1 0.0002
181 SECRETION DISCHARGE 3 0.0002
182 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
183 CARDIAC FAILURE CHRONIC 1 0.0002
184 PURULENT DISCHARGE 1 0.0002
185 IMMOBILE 1 0.0002
186 SARS-COV-2 TEST POSITIVE 3 0.0002
187 PHYSICAL DISABILITY 1 0.0002
188 DISEASE COMPLICATION 1 0.0002
189 IMMUNE THROMBOCYTOPENIA 1 0.0002
190 EYE OPERATION 1 0.0002
191 IRRITABILITY 13 0.0002
192 OXYGEN SATURATION DECREASED 12 0.0002
193 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
194 GAIT INABILITY 7 0.0002
195 SUBCUTANEOUS ABSCESS 1 0.0002
196 HYPOKINESIA 3 0.0002
197 BREATH SOUNDS ABNORMAL 1 0.0002
198 PHLEBITIS 1 0.0002
199 INCREASED UPPER AIRWAY SECRETION 1 0.0002
200 NYSTAGMUS 1 0.0002
201 BRUXISM 1 0.0002
202 DECREASED ACTIVITY 2 0.0002
203 DEVICE DISLOCATION 8 0.0002
204 PALLOR 5 0.0002
205 ASPIRATION 2 0.0002
206 CHOKING SENSATION 1 0.0002
207 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
208 RESPIRATORY DISTRESS 5 0.0002
209 STREPTOCOCCAL INFECTION 1 0.0002
210 OCULAR DISCOMFORT 2 0.0002
211 DYSKINESIA 7 0.0002
212 RALES 1 0.0002
213 URINE ODOUR ABNORMAL 1 0.0002
214 INFUSION SITE SWELLING 1 0.0002
215 PHOTOPSIA 1 0.0002
216 SCREAMING 1 0.0002
217 TOOTH INFECTION 2 0.0002
218 TERMINAL STATE 1 0.0001
219 DEVICE BREAKAGE 6 0.0001
220 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
221 JOINT EFFUSION 1 0.0001
222 DROOLING 1 0.0001
223 EATING DISORDER 3 0.0001
224 BRONCHOSPASM 2 0.0001
225 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
226 INFUSION RELATED REACTION 9 0.0001
227 CEREBRAL DISORDER 1 0.0001
228 BREAST TENDERNESS 1 0.0001
229 APHASIA 4 0.0001
230 DEVICE FAILURE 2 0.0001
231 HYPERTHERMIA 1 0.0001
232 COGNITIVE DISORDER 6 0.0001
233 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
234 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
235 DEVICE ISSUE 11 0.0001
236 HYPERAESTHESIA 1 0.0001
237 SPINAL COMPRESSION FRACTURE 1 0.0001
238 PNEUMONIA ASPIRATION 3 0.0001
239 DISEASE PROGRESSION 14 0.0001
240 ANURIA 1 0.0001
241 SKIN SWELLING 1 0.0001
242 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
243 RESPIRATORY RATE INCREASED 1 0.0001
244 DEVELOPMENTAL DELAY 1 0.0001
245 SPINAL DISORDER 1 0.0001
246 DYSPHAGIA 10 0.0001
247 LETHARGY 6 0.0001
248 ATELECTASIS 1 0.0001
249 SINUS BRADYCARDIA 1 0.0001
250 PARKINSONISM 1 0.0001
251 NASAL CONGESTION 6 0.0001
252 BODY TEMPERATURE DECREASED 1 0.0001
253 SALIVARY HYPERSECRETION 1 0.0001
254 HYPOTHERMIA 1 0.0001
255 FEEDING DISORDER 2 0.0001
256 BLINDNESS 4 0.0001
257 EPILEPSY 3 0.0001
258 VIRAL INFECTION 3 0.0001
259 RASH MACULO-PAPULAR 2 0.0001
260 MALNUTRITION 1 0.0001
261 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
262 GASTRIC HAEMORRHAGE 1 0.0001
263 MUSCLE TWITCHING 2 0.0001
264 ELECTROLYTE IMBALANCE 1 0.0001
265 HYPOXIA 3 0.0001
266 COVID-19 PNEUMONIA 1 0.0001
267 MACULAR DEGENERATION 1 0.0001
268 RESPIRATORY DEPRESSION 1 0.0001
269 MUSCLE SPASTICITY 1 0.0001
270 VOMITING 38 0.0001
271 PHARYNGITIS 1 0.0001
272 PNEUMONIA 26 0.0001
273 AGGRESSION 4 0.0001
274 MUSCLE ATROPHY 1 0.0001
275 CARDIOVASCULAR DISORDER 2 0.0001
276 INTRAOCULAR PRESSURE INCREASED 1 0.0001
277 HYPOPHAGIA 2 0.0001
278 UNRESPONSIVE TO STIMULI 2 0.0001
279 RESPIRATORY TRACT INFECTION 2 0.0001
280 BRADYCARDIA 4 0.0001
281 QUALITY OF LIFE DECREASED 1 0.0001
282 TACHYPNOEA 1 0.0001
283 PERIPHERAL COLDNESS 1 0.0001
284 RESPIRATORY ARREST 2 0.0001
285 INFLUENZA 8 0.0001
286 SINUS TACHYCARDIA 1 0.0001
287 PSYCHOTIC DISORDER 2 0.0001
288 CARDIOMYOPATHY 1 0.0001
289 HAEMORRHAGE INTRACRANIAL 1 0.0001
290 RESPIRATORY DISORDER 2 0.0001
291 ANKLE FRACTURE 1 0.0001
292 EJECTION FRACTION DECREASED 1 0.0001
293 PNEUMOTHORAX 1 0.0001
294 PRODUCTIVE COUGH 3 0.0001
295 RASH ERYTHEMATOUS 3 0.0001
296 SENSORY DISTURBANCE 1 0.0001
297 MOVEMENT DISORDER 2 0.0001
298 SWELLING FACE 4 0.0001
299 MANIA 1 0.0001
300 VENTRICULAR TACHYCARDIA 1 0.0001
301 DRUG LEVEL INCREASED 1 0.0001
302 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
303 VISUAL ACUITY REDUCED 2 0.0001
304 SPEECH DISORDER 3 0.0001
305 DEVICE USE ISSUE 1 0.0001
306 COVID-19 10 0.0001
307 CEREBRAL HAEMORRHAGE 2 0.0001
308 GASTROENTERITIS VIRAL 1 0.0001
309 RESPIRATORY FAILURE 4 0.0001
310 TREATMENT NONCOMPLIANCE 3 0.0001
311 SOMNOLENCE 11 0.0001
312 AGITATION 4 0.0001
313 DYSURIA 2 0.0001
314 BACTERIAL INFECTION 1 0.0001
315 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
316 PHOTOPHOBIA 1 0.0001
317 DYSARTHRIA 2 0.0001
318 HALLUCINATION 4 0.0001
319 FOOT FRACTURE 1 0.0001
320 BLOOD URINE PRESENT 1 0.0001
321 DEHYDRATION 7 0.0001
322 SLEEP APNOEA SYNDROME 1 0.0001
323 POST PROCEDURAL COMPLICATION 1 0.0001
324 ACUTE RESPIRATORY FAILURE 1 0.0001
325 ABNORMAL BEHAVIOUR 2 0.0001
326 COMPLICATION OF DEVICE INSERTION 1 0.0001
327 PRODUCT ADMINISTRATION ERROR 1 0.0000
328 VISUAL IMPAIRMENT 6 0.0000
329 INFECTION 7 0.0000
330 PULMONARY HYPERTENSION 1 0.0000
331 MOUTH ULCERATION 1 0.0000
332 HALLUCINATION, VISUAL 1 0.0000
333 RHINORRHOEA 3 0.0000
334 COUGH 13 0.0000
335 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
336 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
337 TRANSAMINASES INCREASED 1 0.0000
338 TOOTH DISORDER 1 0.0000
339 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
340 CHILLS 5 0.0000
341 TREMOR 7 0.0000
342 COMA 2 0.0000
343 MOBILITY DECREASED 3 0.0000
344 LUNG DISORDER 2 0.0000
345 ENCEPHALOPATHY 1 0.0000
346 AGEUSIA 1 0.0000
347 FEAR 1 0.0000
348 PNEUMONITIS 1 0.0000
349 CARDIAC ARREST 3 0.0000
350 PROCEDURAL PAIN 1 0.0000
351 MENTAL STATUS CHANGES 1 0.0000
352 DEMENTIA 1 0.0000
353 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
354 PAIN IN JAW 1 0.0000
355 HEADACHE 22 0.0000
356 URINARY INCONTINENCE 1 0.0000
357 HEPATIC FAILURE 1 0.0000
358 PLEURAL EFFUSION 2 0.0000
359 GYNAECOMASTIA 1 0.0000
360 FEMUR FRACTURE 1 0.0000
361 MOOD SWINGS 1 0.0000
362 GAIT DISTURBANCE 6 0.0000
363 PRODUCT DOSE OMISSION 2 0.0000
364 CHOLELITHIASIS 1 0.0000
365 STAPHYLOCOCCAL INFECTION 1 0.0000
366 LIP SWELLING 1 0.0000
367 HAEMATURIA 1 0.0000
368 GASTRIC DISORDER 1 0.0000
369 HEART RATE DECREASED 1 0.0000
370 DEVICE MALFUNCTION 2 0.0000
371 SLEEP DISORDER 2 0.0000
372 UNDERDOSE 2 0.0000
373 ACCIDENTAL OVERDOSE 1 0.0000
374 RESTLESSNESS 1 0.0000
375 NASOPHARYNGITIS 5 0.0000
376 HYPERSENSITIVITY 5 0.0000
377 ASTHENIA 10 0.0000
378 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
379 INFLUENZA LIKE ILLNESS 2 0.0000
380 URINARY TRACT INFECTION 4 0.0000
381 BALANCE DISORDER 2 0.0000
382 ANGIOEDEMA 1 0.0000
383 TACHYCARDIA 2 0.0000
384 PULMONARY OEDEMA 1 0.0000
385 THROAT IRRITATION 1 0.0000
386 SWELLING 2 0.0000
387 OCULAR HYPERAEMIA 1 0.0000
388 MIGRAINE 2 0.0000
389 BLOOD GLUCOSE DECREASED 1 0.0000
390 OFF LABEL USE 18 0.0000
391 NAUSEA 16 0.0000
392 HEART RATE INCREASED 2 0.0000
393 SYNCOPE 2 0.0000
394 CELLULITIS 1 0.0000
395 FLUID RETENTION 1 0.0000
396 ILLNESS 2 0.0000
397 PANCREATITIS 1 0.0000
398 DRUG INTERACTION 3 0.0000
399 HYPERTENSION 4 0.0000
400 DISTURBANCE IN ATTENTION 1 0.0000
401 ARTHROPATHY 1 0.0000
402 SEPSIS 2 0.0000
403 WEIGHT DECREASED 5 0.0000
404 URTICARIA 3 0.0000
405 NECK PAIN 1 0.0000
406 EYE PAIN 1 0.0000
407 DECREASED APPETITE 4 0.0000
408 WHEEZING 1 0.0000
409 VERTIGO 1 0.0000
410 DISCOMFORT 1 0.0000
411 FEELING HOT 1 0.0000
412 LOSS OF CONSCIOUSNESS 2 0.0000
413 DRUG INEFFECTIVE 20 0.0000
414 DEATH 13 0.0000
415 VISION BLURRED 2 0.0000
416 BRONCHITIS 1 0.0000
417 DYSGEUSIA 1 0.0000
418 INCORRECT DOSE ADMINISTERED 3 0.0000
419 DYSPNOEA 7 0.0000
420 MUSCULOSKELETAL STIFFNESS 1 0.0000
421 CONTUSION 1 0.0000
422 CONDITION AGGRAVATED 3 0.0000
423 PAIN 6 0.0000
424 CONSTIPATION 2 0.0000
425 MALAISE 4 0.0000
426 FALL 3 0.0000
427 FATIGUE 7 0.0000
428 WEIGHT INCREASED 2 0.0000
429 ASTHMA 1 0.0000
430 HYPERHIDROSIS 1 0.0000
431 INSOMNIA 2 0.0000
432 PRODUCT DOSE OMISSION ISSUE 2 0.0000
433 PAIN IN EXTREMITY 2 0.0000
434 PERIPHERAL SWELLING 1 0.0000
435 CONFUSIONAL STATE 1 0.0000
436 ABDOMINAL DISCOMFORT 1 0.0000
437 TOXICITY TO VARIOUS AGENTS 1 0.0000
438 PRURITUS 2 0.0000
439 ERYTHEMA 1 0.0000
440 DIARRHOEA 3 0.0000
441 DEPRESSION 1 0.0000
442 ABDOMINAL PAIN 1 0.0000
443 DIZZINESS 2 0.0000
444 ANXIETY 1 0.0000
445 ARTHRALGIA 1 0.0000
446 RASH 1 0.0000